Rchr

J-GLOBAL ID：200901062353835487 Update date: Oct. 20, 2021

Itoh Takashi

イトウタカシ | Itoh Takashi

Affiliation and department：
Job title： Professor

Research field (1)： Pharmaceuticals - chemistry and drug development

Research keywords (2)：複素環化学 , Heterocyclic Chemistry

Research theme for competitive and other funds (6)：

不斉触媒を用いた天然物合成研究
一酸化窒素(NO)の有機化学
有機金属を用いた複素環化合物への置換基導入反応
Synthesis of Natural Products using Asymmetric Catalysts.
Organic Chemistry with NO

Show all

MISC (87)：

Daisuke Sano, Kazuhiro Nagata, Takashi Itoh. Catalytic asymmetric hydroxylation of oxindoles by molecular oxygen using a phase-transfer catalyst. ORGANIC LETTERS. 2008. 10. 8. 1593-1595
Daisuke Sano, Kazuhiro Nagata, Takashi Itoh. Catalytic asymmetric hydroxylation of oxindoles by molecular oxygen using a phase-transfer catalyst. ORGANIC LETTERS. 2008. 10. 8. 1593-1595
Kazuhiro Nagata, Yusuke Sekishiro, Takashi Itoh. Diastereoselective construction of indolo[2,3-a]quinolizidine skeleton by cycloaddition reaction of 3,4-dihydro-beta-carbolines with gamma,delta-unsaturated beta-ketoesters. HETEROCYCLES. 2007. 72. 175-179
Kazuhiro Nagata, Yusuke Sekishiro, Takashi Itoh. Diastereoselective construction of indolo[2,3-a]quinolizidine skeleton by cycloaddition reaction of 3,4-dihydro-beta-carbolines with gamma,delta-unsaturated beta-ketoesters. HETEROCYCLES. 2007. 72. 175-179
Kazuhiro Nagata, Daisuke Sano, Takashi Itoh. Catalytic asymmetric alkylation of alpha-cyanocarboxylates using a phase-transfer catalyst. SYNLETT. 2007. 4. 547-550

ｍore...

Education (4)：

- 1983 The University of Tokyo
- 1983 The University of Tokyo Graduate School, Division of Pharmaceutical Sciences
- 1978 The University of Tokyo Faculty of Pharmaceutical Sciences Department of Pharmacy
- 1978 The University of Tokyo Faculty of Pharmaceutical Science

Professional career (1)：

(BLANK) (The University of Tokyo)

Association Membership(s) (3)：

アメリカ化学会 , 日本化学会 , 日本薬学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM